EIGER BIOPHARMACEUTICALS INC

YTD

ALL

Why Robinhood?

You can watch EIGRQ and buy or sell other stocks, ETFs, and their options commission-free!

About EIGRQ

Eiger BioPharmaceuticals, Inc. operates as a biopharmaceutical company, which focuses on the development of innovative therapies for rare metabolic diseases. It is also developing avexitide as a treatment for Post-Bariatric Hypoglycemia.

CEO

David Apelian, MD, PhD

CEODavid Apelian, MD, PhD

Employees

—

Employees—

Headquarters

Palo Alto, California

HeadquartersPalo Alto, California

Founded

2008

Founded2008

Employees

—

Employees—

EIGRQ Key Statistics

Market cap

12.59M

Market cap12.59M

Price-Earnings ratio

-0.17

Price-Earnings ratio-0.17

Dividend yield

—

Dividend yield—

Average volume

507.40

Average volume507.40

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$16.00

52 Week high$16.00

52 Week low

$1.10

52 Week low$1.10

People also own

Based on the portfolios of people who own EIGRQ. This list is generated using Robinhood data, and it’s not a recommendation.